307 related articles for article (PubMed ID: 20517637)
1. Individual and combined soy isoflavones exert differential effects on metastatic cancer progression.
Martínez-Montemayor MM; Otero-Franqui E; Martinez J; De La Mota-Peynado A; Cubano LA; Dharmawardhane S
Clin Exp Metastasis; 2010 Oct; 27(7):465-80. PubMed ID: 20517637
[TBL] [Abstract][Full Text] [Related]
2. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
Raffoul JJ; Banerjee S; Che M; Knoll ZE; Doerge DR; Abrams J; Kucuk O; Sarkar FH; Hillman GG
Int J Cancer; 2007 Jun; 120(11):2491-8. PubMed ID: 17304503
[TBL] [Abstract][Full Text] [Related]
3. The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G.
de la Parra C; Otero-Franqui E; Martinez-Montemayor M; Dharmawardhane S
J Biol Chem; 2012 Dec; 287(50):41640-50. PubMed ID: 23095751
[TBL] [Abstract][Full Text] [Related]
4. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone.
Dong X; Xu W; Sikes RA; Wu C
Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911
[TBL] [Abstract][Full Text] [Related]
5. Positive regulation of hepatic carnitine palmitoyl transferase 1A (CPT1A) activities by soy isoflavones and L-carnitine.
Shin ES; Cho SY; Lee EH; Lee SJ; Chang IS; Lee TR
Eur J Nutr; 2006 Mar; 45(3):159-64. PubMed ID: 16362726
[TBL] [Abstract][Full Text] [Related]
6. Daidzein effect on hormone refractory prostate cancer in vitro and in vivo compared to genistein and soy extract: potentiation of radiotherapy.
Singh-Gupta V; Zhang H; Yunker CK; Ahmad Z; Zwier D; Sarkar FH; Hillman GG
Pharm Res; 2010 Jun; 27(6):1115-27. PubMed ID: 20309614
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
[TBL] [Abstract][Full Text] [Related]
8. Soy-derived isoflavones inhibit the growth of adult T-cell leukemia cells in vitro and in vivo.
Yamasaki M; Fujita S; Ishiyama E; Mukai A; Madhyastha H; Sakakibara Y; Suiko M; Hatakeyama K; Nemoto T; Morishita K; Kataoka H; Tsubouchi H; Nishiyama K
Cancer Sci; 2007 Nov; 98(11):1740-6. PubMed ID: 17727682
[TBL] [Abstract][Full Text] [Related]
9. Lack of combination effects of soy isoflavones and taxane chemotherapy of castration-resistant prostate cancer.
Eskra JN; Schlicht MJ; Bosland MC
Prostate; 2019 Feb; 79(2):223-233. PubMed ID: 30345530
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of soy phytoestrogens on rat L6 skeletal muscle cells.
Jones KL; Harty J; Roeder MJ; Winters TA; Banz WJ
J Med Food; 2005; 8(3):327-31. PubMed ID: 16176142
[TBL] [Abstract][Full Text] [Related]
11. Suppression effect of soy isoflavones on nitric oxide production in RAW 264.7 macrophages.
Sheu F; Lai HH; Yen GC
J Agric Food Chem; 2001 Apr; 49(4):1767-72. PubMed ID: 11308324
[TBL] [Abstract][Full Text] [Related]
12. Multiple mechanisms of soy isoflavones against oxidative stress-induced endothelium injury.
Xu SZ; Zhong W; Ghavideldarestani M; Saurabh R; Lindow SW; Atkin SL
Free Radic Biol Med; 2009 Jul; 47(2):167-75. PubMed ID: 19393315
[TBL] [Abstract][Full Text] [Related]
13. The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alpha.
Tonetti DA; Zhang Y; Zhao H; Lim SB; Constantinou AI
Nutr Cancer; 2007; 58(2):222-9. PubMed ID: 17640169
[TBL] [Abstract][Full Text] [Related]
14. Soy extract has different effects compared with the isolated isoflavones on the proteome of homocysteine-stressed endothelial cells.
Fuchs D; Dirscherl B; Schroot JH; Daniel H; Wenzel U
Mol Nutr Food Res; 2006 Jan; 50(1):58-69. PubMed ID: 16502433
[TBL] [Abstract][Full Text] [Related]
15. Membrane fluidity, invasiveness and dynamic phenotype of metastatic prostate cancer cells after treatment with soy isoflavones.
Ajdžanović V; Mojić M; Maksimović-Ivanić D; Bulatović M; Mijatović S; Milošević V; Spasojević I
J Membr Biol; 2013 Apr; 246(4):307-14. PubMed ID: 23417033
[TBL] [Abstract][Full Text] [Related]
16. Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol.
Mathey J; Mardon J; Fokialakis N; Puel C; Kati-Coulibaly S; Mitakou S; Bennetau-Pelissero C; Lamothe V; Davicco MJ; Lebecque P; Horcajada MN; Coxam V
Osteoporos Int; 2007 May; 18(5):671-9. PubMed ID: 17333448
[TBL] [Abstract][Full Text] [Related]
17. Dietary soy isoflavones increase metastasis to lungs in an experimental model of breast cancer with bone micro-tumors.
Yang X; Belosay A; Hartman JA; Song H; Zhang Y; Wang W; Doerge DR; Helferich WG
Clin Exp Metastasis; 2015 Apr; 32(4):323-33. PubMed ID: 25749878
[TBL] [Abstract][Full Text] [Related]
18. Controlled release of soy isoflavones from multifunctional 3D printed bone tissue engineering scaffolds.
Sarkar N; Bose S
Acta Biomater; 2020 Sep; 114():407-420. PubMed ID: 32652224
[TBL] [Abstract][Full Text] [Related]
19. Soy for breast cancer survivors: a critical review of the literature.
Messina MJ; Loprinzi CL
J Nutr; 2001 Nov; 131(11 Suppl):3095S-108S. PubMed ID: 11694655
[TBL] [Abstract][Full Text] [Related]
20. Soy isoflavones increase quinone reductase in hepa-1c1c7 cells via estrogen receptor beta and nuclear factor erythroid 2-related factor 2 binding to the antioxidant response element.
Froyen EB; Steinberg FM
J Nutr Biochem; 2011 Sep; 22(9):843-8. PubMed ID: 21167702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
